Medical release archive
Here you can find the archive of all Medical releases prior to 2019
Filter by date:
Showing 42 medical releases before 2019
-
New PEGASUS-TIMI 54 sub-analyses provide direction on selecting patients most likely to benefit from long-term treatment with Brilinta (ticagrelor)
-
First patients enrolled in Phase IIIb PONENTE trial evaluating the elimination of oral corticosteroids with Fasenra in severe eosinophilic asthma
-
European Respiratory Journal publishes Phase III TELOS trial for PT009 dual combination therapy in moderate to very severe chronic obstructive pulmonary disease
-
New data from real world evidence indicates need for better secondary prevention to reduce long-term ischaemic risk in heart attack survivors
-
AstraZeneca expands heart failure research with new Phase III DELIVER trial of Forxiga in patients with and without type-2 diabetes
-
Farxiga in combination with Onglyza demonstrates similar glycaemic control with additional benefits vs. insulin glargine in patients with type-2 diabetes
-
AstraZeneca and MedImmune present Phase II data for MEDI0382 at ADA 2018 demonstrating significant improvements in glycaemic control and weight loss in patients with type-2 diabetes
-
AstraZeneca presents Imfinzi (durvalumab) plus tremelimumab combination data at AACR Annual Meeting
-
BRILINTA (ticagrelor) associated with a reduction in risk for cardiovascular events, versus clopidogrel, in heart attack survivors with moderate kidney disease
-
Brilinta meets primary endpoint in Phase III thrombolysis trial
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106